ARQT

NASDAQ · Biotechnology

Arcutis Biotherapeutics Inc

Mid-Cap Stocks Biotech Stocks Healthcare Stocks

$25.96

+0.58 (+2.29%)

As of Sep 21, 9:59 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 12 86%

Hold 2 14%

Sell 0 0%

Price Target

Analyst Price Target +230.4% upside

Low Target $74.20

Average Target $85.78

High Target $112.10

Current Price $25.96

Current
$25.96

Target
$85.78

$74.20 $85.78 avg $112.10

Scenario Analysis

Bear Case

$74.20

185.8%

Low target

Base Case

$85.78

+230.4%

Avg target

Bull Case

$112.10

+331.8%

High target

Risk/Reward

1.8x

Balanced

Price in Context

52-Week High

$31.77

-18.3% from high

52-Week Low

$16.57

+56.7% from low

50-Day SMA

$27.64

-6.1% vs SMA

200-Day SMA

$20.38

+27.4% vs SMA

RSI (14)

67.5

Neutral

Target vs 52W High

$85.78

+170.0% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	82%	$257.58	-2.6%
AMGN Amgen Inc	Hold	43	47%	$190.87	-51.5%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+140.9%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	36	81%	$438.34	-14.2%
REGN Regeneron Pharmaceuticals	Buy	38	68%	$76.80	-90.4%
MRNA Moderna Inc	Hold	30	37%	$149.45	-13.6%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-61.4%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-40.8%